ask="12.55"
ask_size="500"
average_daily_volume="2113810"
bid="11.40"
bid_size="700"
book_value="-0.09"
change="-0.06"
change_from_200_day_moving_average="1.27"
change_from_50_day_moving_average="0.79"
change_from_52_week_high="-2.15"
change_From_52_week_low="5.27"
change_in_percent="-0.49%"
close="12.23"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.87"
ex_dividend_date="N/A"
float_shares="94923000"
high="12.50"
high_52_weeks="14.38"
last_trade_date="2/7/2017"
last_trade_price="12.23"
last_trade_size="64768"
last_trade_time="4:00pm"
low="12.10"
low_52_weeks="6.96"
market_capitalization="1.57B"
moving_average_200_day="10.96"
moving_average_50_day="11.44"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="12.31"
pe_ratio="N/A"
peg_ratio="-0.25"
percent_change_from_200_day_moving_average="+11.56%"
percent_change_from_50_day_moving_average="+6.93%"
percent_change_from_52_week_high="-14.95%"
percent_change_from_52_week_low="+75.72%"
previous_close="12.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.85"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="9.08"
stock_exchange="NMS"
symbol="HALO"
volume="985200"
weeks_range_52="6.96 - 14.38"
